Genomic Valley Biotech Ltd (NSE: GVBL), ISIN INE574D01010 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
GVBL last traded at ₹28.50 (+0.00%), with a 52-week range of ₹20.10 to ₹53.49 (as of 29 Jul 2026).
Shareholding as of Dec 2025: promoters 46.06%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 67/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.